Given what some experts and clinicians cite as a lack of clear evidentiary benefit, FDA approval doesn’t guarantee reimbursement of multi-cancer early detection tests.

A new urine test could identify people with bladder cancer more accurately than current diagnostic methods, researchers found ...

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. Here's what to know.

Researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy ...

The American Cancer Society partners with Baptist Health to boost cancer screening and early detection in South Florida, ...

Breast density is only one piece of the puzzle.

Even though a large proportion of cancer patients carry genetic mutations that make them more susceptible to cancer, only a small percentage of them — and their family members — undergo potentially ...

WEST PALM BEACH, FL / ACCESS Newswire / April 6, 2026 / Advanced Oncosure Testing Inc., ("OncoSure Testing") an early detection cancer screening company focused on non-evasive, and cost efficient ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

The National Comprehensive Cancer Network's two-day Oncology Policy Summit in Washington, D.C. united leaders from the NCI, ...

The National Comprehensive Cancer Network® (NCCN®) hosted a two-day summit focused on expanding access to life-saving cancer prevention and screening. The event examined policy solutions at both the ...